Tag: genomics
-
FDA Approves RNA-Interference Nerve Disease Therapy
A treatment that silences the actions of RNA and reverses damage to nerves from a rare inherited neurological disease was approved by the Food and Drug Administration.
-
Allergan Licensing Crispr for Inherited Eye Disease
Drug maker Allergan is acquiring the rights from Editas Medicine to develop an application of the genome-editing technology Crispr for the inherited eye disease Leber congenital amaurosis type 10.
-
Precision Medicine Technique Devised for Brain Tumors
A process for quickly determining genetic mutations behind brain tumors and delivering a treatment addressing those mutations is shown to extend the survival of lab mice induced with those tumors.
-
![Genetic Testing Shown to Improve IVF Success [Updated]](https://technewslit.com/sciencebusiness/wp-content/uploads/2018/08/PregnantWoman_FreestocksOrg_Unsplash-150x100.jpg)
Genetic Testing Shown to Improve IVF Success [Updated]
A recently published study shows a genetic test for abnormal number of chromosomes conducted with women seeking to become pregnant helps improve their chances for in-vitro fertilization success.
-
Engineered Bacteria Studied for Rare Inherited Skin Disorder
A biotechnology company and research lab are evaluating a modified skin bacteria as a treatment for Netherton syndrome, a rare inherited skin disease affecting mainly infants and young children.
-
Experimental Drug Extends Survival, Reverses Inherited ALS Damage
An experimental drug designed to silence a protein associated with inherited forms of amyotrophic lateral sclerosis, or ALS, is shown in tests with lab rodents to extend survival and reverse some neuromuscular damage.
-
GSK, 23andMe Ink Precision Meds Discovery Deal
Consumer genetics company 23andMe signed a 4-year agreement to help drug maker GlaxoSmithKline find more precise drug targets and recruit clinical trial participants likely to respond to treatments.
-
NSF, Industry Group Fund Bio-Based Semiconductor R&D
A research consortium in the semiconductor industry and National Science Foundation are supporting a series of projects investigating interactions between biology and circuits for data transfer and storage.
-
Gates, Lauder Backing Early Alzheimer’s Biomarker Tests
A group of well-known philanthropists is backing a new research program to find simple tests that reveal early indicators of Alzheimer’s disease in a person’s molecular make-up.
-
More Damage Detected from Crispr-Cas9 Edits
A genetics lab in the U.K. revealed that a leading technique for editing genomes produces more unwanted damage to the edited genomes than previously understood.